Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ruby Siada"'
Autor:
Stefanie Stallard, Masha G. Savelieff, Kyle Wierzbicki, Brendan Mullan, Zachary Miklja, Amy Bruzek, Taylor Garcia, Ruby Siada, Bailey Anderson, Benjamin H. Singer, Rintaro Hashizume, Angel M. Carcaboso, Kaitlin Q. McMurray, Jason Heth, Karin Muraszko, Patricia L. Robertson, Rajen Mody, Sriram Venneti, Hugh Garton, Carl Koschmann
Publikováno v:
Acta Neuropathologica Communications, Vol 6, Iss 1, Pp 1-4 (2018)
Externí odkaz:
https://doaj.org/article/36b293d203c6459a8f4a9bd2839a5f28
Autor:
Liang Zhang, Cody L Nesvick, Charlie A Day, Jonghoon Choi, Victor M Lu, Timothy Peterson, Erica A Power, Jacob B Anderson, Feda H Hamdan, Paul A Decker, Renae Simons, John P Welby, Ruby Siada, Jizhi Ge, Tatiana Kaptzan, Steven A Johnsen, Edward H Hinchcliffe, David J Daniels
Publikováno v:
Neuro-oncology. 24(10)
Background H3K27M-mutant diffuse midline glioma (DMG) is a lethal brain tumor that usually occurs in children. Despite advances in our understanding of its underlying biology, efficacious therapies are severely lacking. Methods We screened a library
Autor:
Sabine Mueller, Rodrigo Cartaxo, Viveka Nand Yadav, Rajen Mody, Cassie Kline, Alyssa Paul, Zachary Miklja, Brendan Mullan, Patricia L. Robertson, Ruby Siada, Marcia Leonard, Sriram Venneti, Taylor Garcia, Amy K. Bruzek, Stefanie Stallard, Hugh J. L. Garton, Bernard L. Marini, Carl Koschmann, Chase Thomas, Kyle Wierzbicki, Jann N. Sarkaria, Arul M. Chinnaiyan, Theodore Nicolaides, Daniel R. Wahl, Sarah Leary, Chandan Kumar-Sinha, Chana Glasser, Hemant Parmar, Jessica R. Cummings, Ian Wolfe, Tao Yang, Timothy N. Phoenix, Manjunath P. Pai
Publikováno v:
J Clin Invest
BackgroundPediatric and adult high-grade glioma (HGG) frequently harbor PDGFRA alterations. We hypothesized that co-treatment with everolimus may improve the efficacy of dasatinib in PDGFRα-driven glioma through combinatorial synergism and increased
Autor:
Dana Messinger, Micah K Harris, Jessica R Cummings, Chase Thomas, Tao Yang, Stefan R Sweha, Rinette Woo, Robert Siddaway, Martin Burkert, Stefanie Stallard, Tingting Qin, Brendan Mullan, Ruby Siada, Ramya Ravindran, Michael Niculcea, Abigail R Dowling, Joshua Bradin, Kevin F Ginn, Melissa A H Gener, Kathleen Dorris, Nicholas A Vitanza, Susanne V Schmidt, Jasper Spitzer, Jiang Li, Mariella G Filbin, Xuhong Cao, Maria G Castro, Pedro R Lowenstein, Rajen Mody, Arul Chinnaiyan, Pierre-Yves Desprez, Sean McAllister, Matthew D Dun, Cynthia Hawkins, Sebastian M Waszak, Sriram Venneti, Carl Koschmann, Viveka Nand Yadav
Publikováno v:
Neuro-oncology.
Background Diffuse midline gliomas (DMG) are highly invasive brain tumors with rare survival beyond two years past diagnosis and limited understanding of the mechanism behind tumor invasion. Previous reports demonstrate upregulation of the protein ID
Autor:
Dana Messinger, Micah Harris, Jessica Cummings, Chase Thomas, Tao Yang, Stefan Sweha, Rinette Woo, Robert Siddaway, Martin Burkert, Stefanie Stallard, Tingting Qin, Brendan Mullan, Ruby Siada, Ramya Ravindran, Michael Niculcea, Abigail Dowling, Joshua Bradin, Kevin Ginn, Melissa Gener, Kathleen Dorris, Nicholas Vitanza, Susanne Schmidt, Jasper Spitzer, Jiang Li, Mariella Filbin, Xuhong Cao, Maria Castro, Pedro Lowenstein, Rajen Mody, Arul Chinnaiyan, Pierre-Yves Desprez, Sean McAllister, Matthew Dun, Cynthia Hawkins, Sebastian Waszak, Sriram Venneti, Carl Koschmann, Viveka Yadav
Publikováno v:
Neuro-Oncology. 24:vii40-vii40
Diffuse midline gliomas (DMG) are highly invasive brain tumors with rare survival beyond two years past diagnosis. The mechanism behind tumor invasion is currently not well understood. Previous reports demonstrate upregulation of the protein ID1 with
Autor:
Tingting Qin, Brendan Mullan, Ramya Ravindran, Dana Messinger, Ruby Siada, Jessica R. Cummings, Micah Harris, Ashwath Muruganand, Kalyani Pyaram, Zachary Miklja, Mary Reiber, Taylor Garcia, Dustin Tran, Carla Danussi, Jacqueline Brosnan-Cashman, Drew Pratt, Xinyi Zhao, Alnawaz Rehemtulla, Maureen A. Sartor, Sriram Venneti, Alan K. Meeker, Jason T. Huse, Meredith A. Morgan, Pedro R. Lowenstein, Maria G. Castro, Viveka Nand Yadav, Carl Koschmann
Publikováno v:
Cell Rep
ATRX, a chromatin remodeler protein, is recurrently mutated in H3F3A-mutant pediatric glioblastoma (GBM) and isocitrate dehydrogenase (IDH)-mutant grade 2/3 adult glioma. Previous work has shown that ATRX-deficient GBM cells show enhanced sensitivity
Autor:
Kevin Ginn, Pierre-Yves Desprez, Micah Harris, Cynthia Hawkins, Michael Niculcea, Chase Thomas, Maria G. Castro, Sriram Venneti, Tao Yang, Melissa Gener, Cummings, Xuhong Cao, Sandra S. McAllister, Stefanie Stallard, Messinger D, Jasper Spitzer, Carl Koschmann, Mariella G. Filbin, Chinnaiyan A, Tingting Qin, Pedro R. Lowenstein, Sebastian M. Waszak, Kathleen Dorris, Jiang Li, Viveka Yadav, Burkert M, Ramya Ravindran, Robert Siddaway, Rinette Woo, Susanne V. Schmidt, Ruby Siada, Rajen Mody, Brendan Mullan, Nicholas A Vitanza
Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive brain tumor with rare survival beyond two years. This poor prognosis is largely due to the tumor’s highly infiltrative and invasive nature. Previous reports demonstrate upregulation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4a6667772b4c5047c8ed9961739ba7e
https://doi.org/10.1101/2021.05.10.443452
https://doi.org/10.1101/2021.05.10.443452
Autor:
Micah Harris, Brendan Mullan, Jacqueline A. Brosnan-Cashman, Carla Danussi, Taylor Garcia, Carl Koschmann, Alnawaz Rehemtulla, Mary Reiber, Zachary Miklja, Sriram Venneti, Kalyani Pyaram, Xinyi Zhao, Tingting Qin, Jessica R. Cummings, Drew Pratt, Dustin Tran, Maureen A. Sartor, Ashwath Muruganand, Ramya Ravindran, Meredith A. Morgan, Alan K. Meeker, Viveka Nand Yadav, Maria G. Castro, Pedro R. Lowenstein, Ruby Siada, Jason T. Huse
Publikováno v:
SSRN Electronic Journal.
ATRX, a chromatin remodeler protein, is recurrently mutated in H3F3A-mutant pediatric glioblastoma (GBM) and IDH-mutant grade 2/3 adult glioma. Previous work has shown that ATRX-deficient GBM cells show enhanced sensitivity to irradiation, but the et
Autor:
Carl Koschmann, Abed Rahman Kawakibi, Rohinton Tarapore, Sharon Gardner, Chase Thomas, Rodrigo Cartaxo, Viveka Yadav, Andrew Chi, Sylvia Kurz, Patrick Wen, Isabel Arrillaga, Tracy Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca Harrison, John De Groot, Minesh Mehta, Yazmin Odia, Matthew Hall, Doured Daghistani, Timothy Cloughesy, Benjamin Ellingson, Michelle Kim, Yoshie Umemura, Hugh Garton, Andrea Franson, Patricia Robertson, Jonathan Schwartz, Bernard Marini, Manjunath Pai, Timothy Phoenix, Sunjong Ji, Evan Cantor, Zachary Miklja, Brendan Mullan, Amy Bruzek, Ruby Siada, Jessica Cummings, Stefanie Stallard, Kyle Wierzbicki, Alyssa Paul, Ian Wolfe, Matthew Dun, Jason Cain, Li Jiang, Mariella Filbin, Pankaj Vats, Chandan Kumar-Sinha, Rajen Mody, Arul Chinnaiyan, Drew Pratt, Sriram Venneti, Guangrong Lu, Sabine Mueller, Adam Resnick, Javad Nazarian, Sebastian Waszak, Joshua Allen
Patients with diffuse midline glioma (DMG) harboring H3 K27M mutation have no proven therapies beyond radiation. ONC201, a DRD2 antagonist and mitochondrial ClpP agonist, has induced early responses in patients with H3 K27M-mutant DMG. We performed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06f1acf7b9e4e63c9e411b7056b9a949
https://doi.org/10.21203/rs.3.rs-69706/v1
https://doi.org/10.21203/rs.3.rs-69706/v1
Autor:
Carl Koschmann, Micah Harris, Sriram Venneti, Sean D. McAllister, Kevin Ginn, Kathleen Dorris, Viveka Nand Yadav, Jasper Spitzer, Mariella G Filbin, Rajen Mody, Stefanie Stallard, Brendan Mullan, Dana Messinger, Pedro R. Lowenstein, Cynthia Hawkins, Jessica R. Cummings, Jiang Li, Nicholas A Vitanza, Ruby Siada, Tao Yang, Sebastian M Waszak, Melissa Gener, Tingting Qin, Robert Siddaway, Ramya Ravindran, Chase Thomas, Xuhong Cao, Maria G. Castro, Martin Burkert, Susanne Schmidt, Pierre Yves Desprez, Arul M. Chinnaiyan, Michael Niculcea, Rinette Woo
Publikováno v:
Neuro Oncol
Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive pediatric brain tumor with rare survival beyond two years. This poor prognosis is largely due to the tumor's highly infiltrative and invasive nature. Nearly 80% of DMGs harbor K27M mutati